Finance

Lists
Why is 4553 up 2.84%?
Dive Deeper
4553:TYO
Towa Pharmaceutical Co Ltd
Â¥3,440.00
+2.84%
(+95.00) 1D
Nov 16, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4553...
Open
Â¥3,395
High
Â¥3,465
Low
Â¥3,385
Mkt. cap
177.22B
Avg. vol.
138.38K
Volume
138.50K
Dividend
2.33%
Quarterly dividend
Â¥20
Ex-dividend date
Mar 30, 2027
P/E ratio
43.40
52-wk high
Â¥4,490
52-wk low
Â¥2,938
EPS
Â¥79
Shares outstanding
16.40M
No. of employees
5K
Open
Â¥3,395
High
Â¥3,465
Low
Â¥3,385
Mkt. cap
177.22B
Avg. vol.
138.38K
Volume
138.50K
Dividend
2.33%
Quarterly dividend
Â¥20
Ex-dividend date
Mar 30, 2027
P/E ratio
43.40
52-wk high
Â¥4,490
52-wk low
Â¥2,938
EPS
Â¥79
Shares outstanding
16.40M
No. of employees
5K
News stories
From web sources and news partners
About Towa Pharmaceutical Co Ltd
CEO-
Employees4.92K
Founded1951
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
Nov 11, 2026
Fiscal period
Q2 2027
- / -
Revenue / Est. (JPY)
70.87B / 70.90B
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
73.59B
69.64B
71.38B
70.87B
Cost of goods sold
45.67B
45.66B
45.28B
45.53B
Cost of revenue
45.67B
45.66B
45.28B
45.53B
Research and development expenses
-
17.94B
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.87B
2.42B
19.58B
19.12B
Operating expense
18.87B
20.37B
19.58B
19.12B
Total operating expenses
64.54B
66.03B
64.86B
64.65B
Operating income
9.05B
3.61B
6.52B
6.23B
Other non operating income
3.31B
-4.49B
1.83B
-1.66B
EBT including unusual items
12.00B
-10.79B
7.94B
1.98B
EBT excluding unusual items
12.01B
-1.29B
8.14B
4.31B
Income tax expense
3.13B
1.05B
2.41B
640.00M
Effective tax rate
26.07%
-9.70%
30.37%
32.41%
Other operating expenses
-
-
-
-
Net income
8.87B
-11.83B
5.53B
1.34B
Net profit margin
12.05%
-16.99%
7.75%
1.88%
Earnings per share
-
-
-
-
Interest and investment income
76.00M
89.00M
75.00M
94.00M
Interest expense
-532.00M
-580.00M
-628.00M
-708.00M
Net interest expenses
-456.00M
-491.00M
-553.00M
-614.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
14.93B
9.66B
11.58B
11.52B
Gain or loss from assets sale
14.00M
14.80B
-2.00M
177.00M
Upcoming events
AI content may include mistakes. Learn more
Google apps